Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Brief Report
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Methodology and Healthcare Policy
Vol. 1, Issue 3, 2014
February 26, 2016 EDT
The Impacts of Breakthrough Drug Classes on Total Healthcare Expenditures
Zeynal Karaca
,
Steven N. Wiggins
,
meps
prescription drugs
healthcare expenditures
drug classes
Copyright Logo
ccby-4.0
Photo by
Haley Lawrence
on
Unsplash
JHEOR
1.
Karaca Z, Wiggins SN. The Impacts of Breakthrough Drug Classes on Total Healthcare Expenditures.
JHEOR
. 2016;1(3):276-295.
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats